Search research articles
Contact Us
Filters
Showing results (41-50 of 86) with videos related to
Page
of 9
Sort By:
International Journal of Molecular Sciences
|
November 14, 2023
Long-Term Tumor Control Following Targeted Alpha Therapy (TAT) of Low-Grade Gliomas (LGGs): A New Treatment Paradigm?
Leszek Krolicki, Jolanta Kunikowska, Dominik Cordier, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
June 17, 2008
Initial direct comparison of 99mTc-TOC and 99mTc-TATE in identifying sites of disease in patients with proven GEP NETs
Jaroslaw B Cwikla, Renata Mikolajczak, Dariusz Pawlak, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
August 23, 2014
N-terminal modifications improve the receptor affinity and pharmacokinetics of radiolabeled peptidic gastrin-releasing peptide receptor antagonists: examples of 68Ga- and 64Cu-labeled peptides for PET imaging
Eleni Gourni, Rosalba Mansi, Mazen Jamous, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
January 17, 2015
Somatostatin receptor-targeted radiopeptide therapy with 90Y-DOTATOC and 177Lu-DOTATOC in progressive meningioma: long-term results of a phase II clinical trial
Nicolas Marincek, Piotr Radojewski, Rebecca A Dumont, et al.
Chemistry & Biology
|
October 21, 2006
Design, synthesis, and biological evaluation of somatostatin-based radiopeptides
Mihaela Ginj, Jörg S Schmitt, Jianhua Chen, et al.
Chemistry (Weinheim an Der Bergstrasse, Germany)
|
January 13, 2010
Tetraamine-derived bifunctional chelators for technetium-99m labelling: synthesis, bioconjugation and evaluation as targeted SPECT imaging probes for GRP-receptor-positive tumours
Keelara Abiraj, Rosalba Mansi, Maria-Luisa Tamma, et al.
Nuclear Medicine and Biology
|
February 2, 2002
Ga-66 labeled somatostatin analogue DOTA-DPhe1-Tyr3-octreotide as a potential agent for positron emission tomography imaging and receptor mediated internal radiotherapy of somatostatin receptor positive tumors
Omer Ugur, Paresh J Kothari, Ronald D Finn, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
July 8, 2003
Clinical usefulness of 99mTc-EDDA/HYNIC-TOC scintigraphy in oncological diagnostics: a preliminary communication
Anna Płachcińska, Renata Mikołajczak, Helmut R Maecke, et al.
Chemistry (Weinheim an Der Bergstrasse, Germany)
|
February 5, 2008
Metal-ion-dependent biological properties of a chelator-derived somatostatin analogue for tumour targeting
Axel Heppeler, João P André, Ingeborg Buschmann, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
August 19, 2010
Development of a potent DOTA-conjugated bombesin antagonist for targeting GRPr-positive tumours
Rosalba Mansi, Xuejuan Wang, Flavio Forrer, et al.
Page
of 9
Search research articles
Search
Showing results (41-50 of 86) with videos related to
Sort By:
Page
of 9
International Journal of Molecular Sciences
|
November 14, 2023
Long-Term Tumor Control Following Targeted Alpha Therapy (TAT) of Low-Grade Gliomas (LGGs): A New Treatment Paradigm?
Leszek Krolicki, Jolanta Kunikowska, Dominik Cordier, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
June 17, 2008
Initial direct comparison of 99mTc-TOC and 99mTc-TATE in identifying sites of disease in patients with proven GEP NETs
Jaroslaw B Cwikla, Renata Mikolajczak, Dariusz Pawlak, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
August 23, 2014
N-terminal modifications improve the receptor affinity and pharmacokinetics of radiolabeled peptidic gastrin-releasing peptide receptor antagonists: examples of 68Ga- and 64Cu-labeled peptides for PET imaging
Eleni Gourni, Rosalba Mansi, Mazen Jamous, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
January 17, 2015
Somatostatin receptor-targeted radiopeptide therapy with 90Y-DOTATOC and 177Lu-DOTATOC in progressive meningioma: long-term results of a phase II clinical trial
Nicolas Marincek, Piotr Radojewski, Rebecca A Dumont, et al.
Chemistry & Biology
|
October 21, 2006
Design, synthesis, and biological evaluation of somatostatin-based radiopeptides
Mihaela Ginj, Jörg S Schmitt, Jianhua Chen, et al.
Chemistry (Weinheim an Der Bergstrasse, Germany)
|
January 13, 2010
Tetraamine-derived bifunctional chelators for technetium-99m labelling: synthesis, bioconjugation and evaluation as targeted SPECT imaging probes for GRP-receptor-positive tumours
Keelara Abiraj, Rosalba Mansi, Maria-Luisa Tamma, et al.
Nuclear Medicine and Biology
|
February 2, 2002
Ga-66 labeled somatostatin analogue DOTA-DPhe1-Tyr3-octreotide as a potential agent for positron emission tomography imaging and receptor mediated internal radiotherapy of somatostatin receptor positive tumors
Omer Ugur, Paresh J Kothari, Ronald D Finn, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
July 8, 2003
Clinical usefulness of 99mTc-EDDA/HYNIC-TOC scintigraphy in oncological diagnostics: a preliminary communication
Anna Płachcińska, Renata Mikołajczak, Helmut R Maecke, et al.
Chemistry (Weinheim an Der Bergstrasse, Germany)
|
February 5, 2008
Metal-ion-dependent biological properties of a chelator-derived somatostatin analogue for tumour targeting
Axel Heppeler, João P André, Ingeborg Buschmann, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
August 19, 2010
Development of a potent DOTA-conjugated bombesin antagonist for targeting GRPr-positive tumours
Rosalba Mansi, Xuejuan Wang, Flavio Forrer, et al.
Page
of 9